The Economic Times

Anupam Rasayan to acquire up to 43 pc stake in Bliss GVS Pharma for around Rs 1,369 cr

Specialty chemicals maker Anupam Rasayan India is set to acquire up to 43.3% of Bliss GVS Pharma for an estimated Rs 1,369.51 crore, with an open offer for an additional 26%. This strategic move aims to strengthen Anupam Rasayan's presence across the pharmaceutical value chain, from key starting materials to finished dosage formulations.